MOTS-c 40mg

Contents

Use this guide as a structured review page. The same headings appear for every protocol so clients and the care team can scan the page consistently.

Quickstart Highlights

MOTS-c is a 16–amino-acid mitochondrial-derived peptide (MDP) that acts as a metabolic regulator, primarily through AMPK activation[1][2]. Preclinical studies show it enhances insulin sensitivity, promotes fat oxidation, improves exercise capacity, and counters age-related metabolic decline[1][4]. No clinical trials have been completed in humans to date[8]. This educational protocol presents a once-daily subcutaneous approach with gradual titration.

• Reconstitute: Add 3.0 mL bacteriostatic water → ~6.67 mg/mL concentration.
• Typical daily range: 200–1,000 mcg once daily (gradual titration over 10 weeks).
• Easy measuring: At 6.67 mg/mL, 1 unit = 0.01 mL ≈ 66.7 mcg on a U‑100 insulin syringe.
• Storage: Lyophilized: freeze at −20 °C (−4 °F) or below; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and use within 7 days for best potency.

Dosing & Reconstitution Guide

Educational guide for reconstitution and daily dosing

• Frequency: Inject once daily subcutaneously[7]. Stay at each dose level for approximately 2 weeks before increasing, and monitor for any adverse reactions[7].
• For ≤10‑unit (≤0.10 mL) administrations, consider 30‑ or 50‑unit insulin syringes for improved readability.

Reconstitution Steps

Evidence context (important): The table above is a conversion aid for a 5 mg vial reconstituted to 3.0 mL. It is not a clinical recommendation. Published MGF literature is largely preclinical (e.g., muscle and cardiocerebral models) and uses local or systemic routes distinct from subcutaneous daily regimens.[1][3][4][5][6]

• Draw 3.0 mL bacteriostatic water with a sterile syringe.
• Inject slowly down the vial wall; avoid foaming.
• Gently swirl/roll until dissolved (do not shake vigorously).
• Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
• Use within 7 days for optimal potency[7]. Open source

Supplies Needed

Plan based on an 8–16 week daily protocol with gradual titration.

• Peptide Vials (MOTS-C, 20 mg each):
• Peptide Vials (MOTS-C, 20 mg each):: 8 weeks ≈ 2 vials
• Peptide Vials (MOTS-C, 20 mg each):: 12 weeks ≈ 3 vials
• Peptide Vials (MOTS-C, 20 mg each):: 16 weeks ≈ 5 vials
• Insulin Syringes (U‑100):
• Insulin Syringes (U‑100):: Per week: 7 syringes (1/day)
• Insulin Syringes (U‑100):: 8 weeks: 56 syringes
• Insulin Syringes (U‑100):: 12 weeks: 84 syringes
• Insulin Syringes (U‑100):: 16 weeks: 112 syringes
• Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.
• Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.: 8 weeks (2 vials): 6 mL → 1 × 10 mL bottle
• Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.: 12 weeks (3 vials): 9 mL → 1 × 10 mL bottle
• Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.: 16 weeks (5 vials): 15 mL → 2 × 10 mL bottles
• Alcohol Swabs: One for the vial stopper + one for the injection site each day.
• Alcohol Swabs: One for the vial stopper + one for the injection site each day.: Per week: 14 swabs (2/day)
• Alcohol Swabs: One for the vial stopper + one for the injection site each day.: 8 weeks: 112 swabs → recommend 2 × 100‑count boxes
• Alcohol Swabs: One for the vial stopper + one for the injection site each day.: 12 weeks: 168 swabs → recommend 2 × 100‑count boxes
• Alcohol Swabs: One for the vial stopper + one for the injection site each day.: 16 weeks: 224 swabs → recommend 3 × 100‑count boxes

Protocol Overview

Concise summary of the once‑daily regimen.

• Goal: Support metabolic homeostasis, insulin sensitivity, and age-related physical performance based on preclinical evidence[1][2][4]. Open source
• Schedule: Daily subcutaneous injections for 8–12 weeks (extend to 16 weeks if desired).
• Dose Range: 200–1,000 mcg daily with gradual titration over 10 weeks.
• Reconstitution: 3.0 mL per 20 mg vial (~6.67 mg/mL) for accurate unit measurements.
• Storage: Lyophilized frozen at −20 °C (−4 °F); reconstituted refrigerated at 2–8 °C (35.6–46.4 °F); avoid repeated freeze–thaw.

Dosing Protocol

Suggested daily titration approach based on animal-to-human extrapolation.

• Start: 200 mcg daily for 2 weeks.
• Titration: Increase by ~200 mcg every 2 weeks: 400 mcg (Weeks 3–4), 600 mcg (Weeks 5–6), 800 mcg (Weeks 7–8).
• Target: Up to 1,000 mcg (1.0 mg) daily by Weeks 9–10+ if well tolerated[7]. Open source
• Frequency: Once per day (subcutaneous).
• Cycle Length: 8–12 weeks; optional extension to 16 weeks.
• Timing: Any consistent time; rotate injection sites.

Storage Instructions

Proper storage preserves peptide quality and potency.

• Lyophilized: Store at −20 °C (−4 °F) or below in dry, dark conditions; include desiccant if available to minimize moisture exposure.
• Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); peptide degrades rapidly at room temperature (~25% activity loss after 24 hours at 4 °C)[7]. Use within 7 days for best potency. Open source
• Aliquoting: Prepare single-use aliquots and freeze at −20 °C (−4 °F) if needed; avoid freeze–thaw cycles.
• Allow vials to reach room temperature before opening to reduce condensation uptake.

Important Notes

Practical considerations for consistency and safety.

• Use new sterile insulin syringes for each injection; dispose in a sharps container[11]. Open source
• Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation and prevent lipohypertrophy[11]. Open source
• Inject slowly; wait a few seconds before withdrawing the needle.
• Document daily dose, injection site, and any observations to maintain consistency.
• Discontinue use and consult a medical professional if any concerning symptoms arise.

How This Works

MOTS-c functions as a metabolic “stress signal” that helps optimize energy usage during nutrient stress or exercise[2]. Its primary mechanism is AMPK activation through inhibition of the folate cycle, causing accumulation of AICAR (an AMP analog)[1][2]. Activated AMPK shifts cells into an energy-efficient mode – enhancing glucose uptake, fatty-acid oxidation, and mitochondrial respiration while downregulating fat storage and gluconeogenesis[2].

• MOTS-c can also translocate to the cell nucleus under stress conditions and upregulate antioxidant and stress-response genes[2]. This retrograde signaling from mitochondria to nucleus increases expression of cytoprotective enzymes, helping cells cope with oxidative stress. Research indicates MOTS-c may also modulate mTOR and inflammatory pathways, contributing to lifespan and healthspan effects[10]. Its actions resemble those of exercise and metformin at a cellular level[2], making it of great interest for metabolic disorders, obesity, and aging research.

Lifestyle Factors

Complementary strategies for best outcomes based on MOTS-c’s metabolic mechanisms.

• Pair with a balanced, protein-forward diet tailored to energy needs.
• Combine resistance training and aerobic activity to reinforce metabolic adaptations and AMPK signaling[4][8]. Open source
• Prioritize sleep (7–9 hours) and stress management to support mitochondrial health and recovery.
• Consider intermittent fasting or caloric restriction, which may synergize with MOTS-c’s AMPK-mediated effects.

Potential Benefits & Side Effects

Observations from preclinical literature (no human clinical trials completed to date)[8]:

• Metabolic Health: Improves insulin sensitivity and glucose metabolism in mouse models; prevents diet-induced insulin resistance[1][7]. Open source
• Weight & Fat Reduction: Prevents obesity and reduces visceral fat in obese mice through increased energy expenditure and fat oxidation[1][7]. Open source
• Post-Menopausal Metabolism: Mitigates metabolic decline in ovariectomized mice; prevents menopause-related fat gain and insulin resistance[3]. Open source
• Physical Performance: Enhances exercise capacity and counters age-related frailty; old mice ran 2× longer on treadmill tests[4][7]. Open source
• Organ Protection: Reduces liver fat accumulation, improves cardiac function, and may support cognitive function in preliminary studies[2][7]. Open source
• Bone & Immunity: Promotes osteoblast activity, inhibits osteoclast formation; modulates immune aging and protects pancreatic islet cells in autoimmune diabetes models[5][10]. Open source
• Safety: No adverse effects reported in preclinical studies; human tolerability unknown. A modified analog (CB4211) showed good tolerability in a Phase 1 trial[7]. Open source
• Note: These benefits have been demonstrated only in controlled research settings (mice or cells). Translation to humans requires clinical studies.

Injection Technique

General subcutaneous guidance from clinical best‑practice resources[9][11]:

• Clean the vial stopper and skin with alcohol; allow to dry completely.
• Pinch a skinfold; insert the needle at 90° (45° if very lean) into subcutaneous tissue[11]. Open source
• Do not aspirate for subcutaneous injections; inject slowly and steadily over a few seconds[9]. Open source
• Withdraw needle at the same angle; apply gentle pressure if bleeding occurs (do not rub).
• Rotate sites systematically (abdomen at least 2 inches from navel, outer thighs, back of upper arms) to avoid irritation and lipohypertrophy[11]. Open source
• Dispose of used syringes immediately in a proper sharps container (never reuse needles)[11]. Open source

Recommended Source

We recommend Prime Lab Peptides for high‑purity MOTS-C (20 mg).

• High‑purity, third‑party‑tested lots with batch Certificates of Analysis (COAs).
• Consistent, ISO‑aligned handling and documentation.
• Reliable fulfillment to maintain cold‑chain integrity.

Important Note

This page is informational and does not authorize use. Peptify clients should complete assessment, disclose medications and health history, and follow the clinician-approved plan only.

• Do not start, stop, combine, or change a protocol based only on website content.
• Emergency symptoms require urgent medical care, not a website or routine follow-up message.

References

Reference-derived details for MOTS-c 40mg.

• MOTS-C (20 mg Vial) Open source
• Cell Metabolism (2015) — The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance (Lee C, Zeng J, Drew BG, et al.) View Source Open source
• Journal of Translational Medicine (2023) — Mitochondria-derived peptide MOTS-c: effects and mechanisms related to stress, metabolism and aging (Wan W, Zhang L, Lin Y, et al.) View Source Open source
• Journal of Molecular Medicine (2019) — MOTS-c peptide regulates adipose homeostasis to prevent ovariectomy-induced metabolic dysfunction (Lu H, Wei M, Zhai Y, et al.) View Source Open source
• Nature Communications (2021) — MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis (Reynolds JC, Lai RW, Woodhead JST, et al.) View Source Open source
• Frontiers in Physiology (2023) — Role of MOTS-c in the regulation of bone metabolism (Yi X, Hu G, Yang Y, et al.) View Source Open source
• International Journal of Molecular Sciences (2022) — MOTS-c, the Most Recent Mitochondrial Derived Peptide in Human Aging and Age-Related Diseases (Mohtashami Z, Singh MK, Salimiaghdam N, et al.) View Source Open source
• Cognitive Vitality Reports (2021) — MOTS-c (Cognitive Vitality Profile) – Alzheimer’s Drug Discovery Foundation (ADDF) View Source Open source
• USADA Spirit of Sport (2023) — What is the MOTS-c peptide? – U.S. Anti-Doping Agency education article View Source Open source
• CDC Vaccine Administration Guidelines — Subcutaneous route technique (angle, site selection, no aspiration) View Source Open source
• Experimental & Molecular Medicine (2025) — Mitochondrial-encoded peptide MOTS-c prevents pancreatic islet cell senescence to delay diabetes (Kong BS, Lee H, L’Yi S, et al.) View Source Open source
• MedlinePlus Medical Encyclopedia (2023) — Subcutaneous (SQ) injections – Patient instructions for proper technique View Source Open source
• Subcutaneous Drug Injection Review (PMC) — Literature review of factors influencing subcutaneous injection pharmacology View Source Open source
• Prime Lab Peptides — MOTS-C (20 mg) product page (quality and batch documentation) View Source